Tech Company Financing Transactions
Avalanche Biotech Funding Round
On 9/8/2014, Avalanche Biotech raised $10 million in funding from private investors.
Transaction Overview
Company Name
Announced On
9/8/2014
Transaction Type
Venture Equity
Amount
$9,999,995
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1035 O'Brien Dr. A
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Avalanche develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat ophthalmologic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leone Patterson
Chief Medical Officer
Aaron Osborne
Chief Technical Officer
Thomas Leung
President
Mehdi Gasmi
VP - General Counsel
Jennifer Cheng
VP - Regulatory Affairs
Carla Fiankan
Browse more venture capital transactions:
Prev: 9/8/2014: Lob venture capital transaction
Next: 9/8/2014: First Wave Products venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs